26th Annual Meeting of the Society of Immunotherapy of Cancer (SITC) November 3, 2011

The 26th Annual Meeting of the SITC will include dynamic presentations, interactive panel discussions and scientific posters on the most timely topics in cancer immunotherapy. The event will also highlight vital information on clinical trial design and regulatory issues to advance collaboration and translation of cancer immunotherapies. Topics of the sessions and poster presentations will include the immunobiology and application of dendritic cells, engineered receptors and adoptive cell therapies, inflammatory infiltrates in cancer, the immunology and immunotherapy of prostate cancer, cancer stem cells, state of the art animal models, uncoupling negative regulation in the tumor microenvironment, and high throughput technologies for immune monitoring.

Alan Wayne will present “Phase I study of the anti-cd22 immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in pediatric patients with acute lymphoblastic leukemia (ALL) - updated results.”